Adynxx, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-06-11: Reporting owner GONZALEZ DINA; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-06-11: Reporting owner GONZALEZ DINA; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-06-11: Reporting owner GONZALEZ DINA; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-06-11: Reporting owner GONZALEZ DINA; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-06-11 holding as of filing | GONZALEZ DINA Officer (CONTROLLER) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.11 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | GONZALEZ DINA Officer (CONTROLLER) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.11 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | GONZALEZ DINA Officer (CONTROLLER) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.39 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | GONZALEZ DINA Officer (CONTROLLER) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.39 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | GONZALEZ DINA Officer (CONTROLLER) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.06 exercise price | 2019-06-11 | ||
| 2019-05-03 | ABEL STAN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +198 198 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | ABEL STAN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,940 27,940 owned after | $3.06 exercise price | 2019-05-07 | |
| 2019-05-03 | WEBER ECKARD Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Trust | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +396 396 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | WEBER ECKARD Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Trust | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,879 55,879 owned after | $3.06 exercise price | 2019-05-07 | |
| 2019-05-03 | Podlesak Dennis Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +396 396 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | Podlesak Dennis Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,879 55,879 owned after | $3.06 exercise price | 2019-05-07 | |
| 2019-05-03 | MAMET JULIEN Director, Officer (CHIEF SCIENTIFIC OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33 33 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | MAMET JULIEN Director, Officer (CHIEF SCIENTIFIC OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +158,149 158,149 owned after | $3.06 exercise price | 2019-05-07 | |
| 2019-05-03 | Manning Donald C. Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,858 23,858 owned after | $1.11 exercise price | 2019-05-07 | |
| 2019-05-03 | Manning Donald C. Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,887 7,887 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | Manning Donald C. Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,943 3,943 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | Manning Donald C. Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,407 56,407 owned after | $3.06 exercise price | 2019-05-07 | |
| 2019-05-03 | ORR RICK Director, Officer (CHIEF EXECUTIVE OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +661 661 owned after | $1.39 exercise price | 2019-05-07 | |
| 2019-05-03 | ORR RICK Director, Officer (CHIEF EXECUTIVE OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +95,417 95,417 owned after | $3.06 exercise price | 2019-05-07 |